Get the app!
Back to Trades

MACKAY MARTIN

DirectorCIK: 0001414815

MACKAY MARTIN, Director, has filed 4 insider trading reports covering 3 companies. Total disclosed trading volume is $1.2M. Purchases and sales are approximately balanced over this period. The largest single filing involves Kailera Therapeutics, Inc. (KLRA). All transactions sourced from SEC Form 4 filings.

Total Volume
$1.2M
Purchases
$0
Sales
$0
Companies
3

Companies Traded

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Kailera Therapeutics, Inc. (KLRA)Rallybio Corp (RLYB)

Trading History (4 filings)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.(CRL)
MACKAY MARTINDirector
Filed May 11, 2026
Grant
$505.3K
2 grants
View DetailsSEC Filing
Kailera Therapeutics, Inc.(KLRA)
MACKAY MARTINInsider
Filed Apr 20, 2026
Other
$0
View DetailsSEC Filing
Kailera Therapeutics, Inc.(KLRA)
MACKAY MARTINInsider
Filed Apr 16, 2026
Other
$0
View DetailsSEC Filing
Rallybio Corp(RLYB)
MACKAY MARTINDirector
Filed Feb 20, 2026
Other
$0
View DetailsSEC Filing